Journey Medical Corporation (DERM)

Journey Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	24.09	20.31	27.44	32	49.08
Cash & Short-Term Investments	24.09	20.31	27.44	32	49.08
Cash Growth	18.64%	-26.00%	-14.26%	-34.80%	495.21%
Accounts Receivable	29.78	10.23	15.22	28.21	23.11
Inventory	9.62	14.43	10.21	14.16	9.86
Other Current Assets	3.38	3.21	3.59	3.31	2.44
Total Current Assets	66.87	48.18	56.46	77.68	84.49
Net Property, Plant & Equipment	0.11	0.2	0.1	0.19	0.09
Other Intangible Assets	27.61	31.86	20.29	27.2	12.55
Other Long-Term Assets	-	-	0.01	0.1	0.15
Total Assets	94.59	80.24	76.85	105.16	97.28
Accounts Payable	9.31	16.58	18.34	36.98	23.45
Accrued Expenses	27.97	17.83	20.37	19.55	22.73
Short-Term Debt	-	-	-	2.95	0.81
Current Portion of Leases	0.1	0.08	0.1	0.08	0.1
Other Current Liabilities	0.07	0.69	3.05	7.27	4.52
Total Current Liabilities	37.44	35.18	41.87	66.83	51.61
Long-Term Debt	25.28	24.88	14.62	19.83	-
Long-Term Leases	0.02	0.12	0.01	0.11	-
Other Long-Term Liabilities	-	-	-	1.41	3.63
Total Long-Term Liabilities	25.3	25	14.63	21.35	3.63
Total Liabilities	62.74	60.17	56.5	88.18	55.24
Common Stock	0	0	0	0	0
Additional Paid-in Capital	130.31	107.09	92.7	85.48	80.92
Retained Earnings	-98.46	-87.03	-72.36	-68.5	-38.87
Shareholders' Equity	31.85	20.07	20.35	16.98	42.04
Total Liabilities & Equity	94.59	80.24	76.85	105.16	97.28
Total Debt	25.4	25.08	14.73	22.97	0.91
Net Cash (Debt)	-1.31	-4.78	12.71	9.04	48.17
Net Cash Growth	-	-	40.62%	-81.24%	1593.78%
Net Cash Per Share	-0.05	-0.23	0.70	0.52	4.73
Book Value	31.85	20.07	20.35	16.98	42.04
Book Value Per Share	1.30	0.98	1.12	0.97	4.13
Tangible Book Value	4.25	-11.79	0.06	-10.22	29.49
Tangible Book Value Per Share	0.17	-0.58	0.00	-0.58	2.90

Updated Mar 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q